BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8800210)

  • 1. Autonomous and reversible folding of a soluble amino-terminally truncated segment of the mouse prion protein.
    Hornemann S; Glockshuber R
    J Mol Biol; 1996 Sep; 261(5):614-9. PubMed ID: 8800210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein.
    Liemann S; Glockshuber R
    Biochemistry; 1999 Mar; 38(11):3258-67. PubMed ID: 10079068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
    Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
    Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NMR structure of the mouse prion protein domain PrP(121-231).
    Riek R; Hornemann S; Wider G; Billeter M; Glockshuber R; Wüthrich K
    Nature; 1996 Jul; 382(6587):180-2. PubMed ID: 8700211
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion and doppel proteins bind to granule cells of the cerebellum.
    Legname G; Nelken P; Guan Z; Kanyo ZF; DeArmond SJ; Prusiner SB
    Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16285-90. PubMed ID: 12446843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial prion disease mutation alters the secondary structure of recombinant mouse prion protein: implications for the mechanism of prion formation.
    Cappai R; Stewart L; Jobling MF; Thyer JM; White AR; Beyreuther K; Collins SJ; Masters CL; Barrow CJ
    Biochemistry; 1999 Mar; 38(11):3280-4. PubMed ID: 10079070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-level expression and characterization of a purified 142-residue polypeptide of the prion protein.
    Mehlhorn I; Groth D; Stöckel J; Moffat B; Reilly D; Yansura D; Willett WS; Baldwin M; Fletterick R; Cohen FE; Vandlen R; Henner D; Prusiner SB
    Biochemistry; 1996 Apr; 35(17):5528-37. PubMed ID: 8611544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solution structure of Syrian hamster prion protein rPrP(90-231).
    Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
    Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Unfolding chaperone as a prion protein relating molecule].
    Hachiya NS; Sakasegawa Y; Kaneko K
    Rinsho Shinkeigaku; 2003 Nov; 43(11):817-9. PubMed ID: 15152473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physical studies of conformational plasticity in a recombinant prion protein.
    Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
    Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. UV-light-induced conversion and aggregation of prion proteins.
    Redecke L; Binder S; Elmallah MI; Broadbent R; Tilkorn C; Schulz B; May P; Goos A; Eich A; Rübhausen M; Betzel C
    Free Radic Biol Med; 2009 May; 46(10):1353-61. PubMed ID: 19249347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expansion of the octarepeat domain alters the misfolding pathway but not the folding pathway of the prion protein.
    Leliveld SR; Stitz L; Korth C
    Biochemistry; 2008 Jun; 47(23):6267-78. PubMed ID: 18473442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extremely rapid folding of the C-terminal domain of the prion protein without kinetic intermediates.
    Wildegger G; Liemann S; Glockshuber R
    Nat Struct Biol; 1999 Jun; 6(6):550-3. PubMed ID: 10360358
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photo-induced crosslinking of prion protein oligomers and prions.
    Piening N; Weber P; Högen T; Beekes M; Kretzschmar H; Giese A
    Amyloid; 2006 Jun; 13(2):67-77. PubMed ID: 16911960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Motif-grafted antibodies containing the replicative interface of cellular PrP are specific for PrPSc.
    Moroncini G; Kanu N; Solforosi L; Abalos G; Telling GC; Head M; Ironside J; Brockes JP; Burton DR; Williamson RA
    Proc Natl Acad Sci U S A; 2004 Jul; 101(28):10404-9. PubMed ID: 15240877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective oxidation of methionine residues in prion proteins.
    Wong BS; Wang H; Brown DR; Jones IM
    Biochem Biophys Res Commun; 1999 Jun; 259(2):352-5. PubMed ID: 10362513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clustered negative charges on the lipid membrane surface induce beta-sheet formation of prion protein fragment 106-126.
    Miura T; Yoda M; Takaku N; Hirose T; Takeuchi H
    Biochemistry; 2007 Oct; 46(41):11589-97. PubMed ID: 17887730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing misfolding of the prion protein by trimethylamine N-oxide.
    Bennion BJ; DeMarco ML; Daggett V
    Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PrP N-terminal domain triggers PrP(Sc)-like aggregation of Dpl.
    Erlich P; Cesbron JY; Lemaire-Vieille C; Curt A; Andrieu JP; Schoehn G; Jamin M; Gagnon J
    Biochem Biophys Res Commun; 2008 Jan; 365(3):478-83. PubMed ID: 17997980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A scrapie-like unfolding intermediate of the prion protein domain PrP(121-231) induced by acidic pH.
    Hornemann S; Glockshuber R
    Proc Natl Acad Sci U S A; 1998 May; 95(11):6010-4. PubMed ID: 9600908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.